Peroxisome proliferator-activated receptor-alpha (PPAR-α), a ligand-activated transcription factor, has emerged as a popular drug target for hyperlipidemia and inflammation in recent years [5]–[7]. The gene discussed is PPARA; the disease is hyperlipidemia.